Affiliation:
1. Division of Cardiology, University of Louisville, Louisville, KY 40202, USA
Abstract
Fabry disease (FD) is a rare, X-linked inherited disorder of glycosphingolipid metabolism. It leads to the progressive accumulation of globotriaosylceramide within lysosomes due to a deficiency of α-galactosidase A enzyme. It involves multiple organs, predominantly the renal, cardiac, and cerebrovascular systems. Early diagnosis and treatment are critical to prevent progression to irreversible tissue damage and organ failure, and to halt life-threatening complications that can significantly reduce life expectancy. This review will focus on the established and emerging treatment options for FD.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference107 articles.
1. Left ventricular hypertrophy in Fabry disease: A practical approach to diagnosis;Yousef;Eur. Hear. J.,2012
2. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons;Gersh;J. Am. Coll. Cardiol.,2011
3. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy;Semsarian;J. Am. Coll. Cardiol.,2015
4. Adam, M.P., Everman, D.B., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J., Gripp, K.W., and Amemiya, A. (2022, August 23). Fabry Disease, GeneReviews, Available online: http://www.ncbi.nlm.nih.gov/books/NBK1292/.
5. Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry;Eng;J. Inherit. Metab. Dis.,2007
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献